After Re-examination, CHMP Recommends Approval of DAYBU for Rett Syndrome in the EU

Acadia’s DAYBU gets EU positive opinion for Rett syndrome; could become first approved treatment for symptoms in Europe.

After Re-examination, CHMP Recommends Approval of DAYBU for Rett Syndrome in the EU
Credit: Acadia Pharmaceuticals
Already have an account? Sign in.